Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe M Weinstein

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Harvard Review of Psychiatry|September 15, 2021
Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar StrokeCristina Montalvo, Amanda von Horn, Chadrick E Lane, et al.
Drug and Alcohol Dependence|May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohortJake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
Journal of Substance Abuse Treatment|October 13, 2017
A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiencesDavida M Schiff, Mari-Lynn Drainoni, Zoe M Weinstein, et al.
Journal of Substance Abuse Treatment|July 5, 2017
Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphineDavid Hui, Zoe M Weinstein, Debbie M Cheng, et al.
Drug and Alcohol Dependence|November 20, 2016
Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphineZoe M Weinstein, Debbie M Cheng, Emily Quinn, et al.
Journal of Substance Abuse Treatment|July 5, 2017
Addiction consultation services - Linking hospitalized patients to outpatient addiction treatmentPaul Trowbridge, Zoe M Weinstein, Todd Kerensky, et al.
Drug and Alcohol Dependence|May 8, 2021
Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital dischargePayel J Roy, Ryan Price, Sugy Choi, et al.
The International Journal on Drug Policy|September 1, 2021
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housingMiriam Th Harris, Rebecca K Seliga, Nadia Fairbairn, et al.
Journal of Addiction Medicine|June 25, 2019
Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods StudyHasmeena Kathuria, Ryan G Seibert, Vinson Cobb, et al.
The Lancet. Public Health|December 3, 2021
Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling studyJoshua A Barocas, Alexandra Savinkina, Joella Adams, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Harvard Review of Psychiatry|September 15, 2021
Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar StrokeCristina Montalvo, Amanda von Horn, Chadrick E Lane, et al.
Drug and Alcohol Dependence|May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohortJake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
Journal of Substance Abuse Treatment|October 13, 2017
A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiencesDavida M Schiff, Mari-Lynn Drainoni, Zoe M Weinstein, et al.
Journal of Substance Abuse Treatment|July 5, 2017
Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphineDavid Hui, Zoe M Weinstein, Debbie M Cheng, et al.
Drug and Alcohol Dependence|November 20, 2016
Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphineZoe M Weinstein, Debbie M Cheng, Emily Quinn, et al.
Journal of Substance Abuse Treatment|July 5, 2017
Addiction consultation services - Linking hospitalized patients to outpatient addiction treatmentPaul Trowbridge, Zoe M Weinstein, Todd Kerensky, et al.
Drug and Alcohol Dependence|May 8, 2021
Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital dischargePayel J Roy, Ryan Price, Sugy Choi, et al.
The International Journal on Drug Policy|September 1, 2021
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housingMiriam Th Harris, Rebecca K Seliga, Nadia Fairbairn, et al.
Journal of Addiction Medicine|June 25, 2019
Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods StudyHasmeena Kathuria, Ryan G Seibert, Vinson Cobb, et al.
The Lancet. Public Health|December 3, 2021
Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling studyJoshua A Barocas, Alexandra Savinkina, Joella Adams, et al.
Pageof 6